Centro de Documentação da PJ
Monografia

390122.D.90
CD371
European Monitoring Centre for Drugs and Drug Addiction
Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs / EMCDDA.- Luxembourg : Office for Official Publications of the European Communities, 2002.- 116 p. ; 21 cm. - (3)
ISBN 92-9168-123-7

DROGA SINTÉTICA, TOXICODEPENDÊNCIA, COMBATE À DROGA, ANÁLISE DE DROGA, OEDT

Foreword / Georges Estievenart. Introduction. Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Europol-EMCDDA progress report on ketamine in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of ketamine in human medicine in the EU Member States (EMEA). Use of ketamine in veterinary medicine in the EU Member States (EMEA). Review of the pharmacotoxicological data on ketamine (2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone). Sociological and criminological (Europol) evidence. Public health risks — epidemiological evidence. References. Participants in the risk-assessment process.